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Chemokine Receptors and HIV-1: Minireview
An Attractive Pair?
Paul Bates In addition, CD4 can induce conformational changes in
the viral glycoproteins, as measured by antibody epi-Department of Microbiology
School of Medicine tope changes and gp120 shedding from the virus (re-
viewed by Sattentau and Moore, 1993), but viral bindingUniversity of Pennsylvania
Philadelphia, Pennsylvania 19104-6100 and these conformational changes are not sufficient for
HIV-1 infection of cells. In nonhuman cells expressing
Binding of virus particles to the host cell surface initiates CD4, HIV-1 binds, but virus–host membrane fusion does
not occur. This species tropism of HIV-1 suggests thata cascade of events that culminates with the introduc-
tion of the viral genetic material into the host cell. For an accessory factor may be required, in addition to CD4,
to elicit the correct alterations in Env that lead to mem-enveloped viruses, this cascade begins with the enve-
lope proteins on the virus binding to specific cellular brane fusion.
In addition to the species-specific restriction to HIV-1receptors and is completed following viral glycoprotein–
mediated fusion of the viral and target membranes. host range outlined above, there are also restrictions
on HIV-1 infection of human cells (reviewed by MiedemaPresently, the best model for viral envelope–mediated
membrane fusion is that of influenza hemaglutinnin (HA). et al., 1994). Most commonly used laboratory strains of
HIV-1 readily infect cultured T cell lines and primary THA mediates membrane fusion by first binding to its
cognate receptor on the host membrane. After endocy- lymphocytes but not primary monocytes or macro-
phages. These strains are termed T-tropic. Some pri-tosis, pH-induced conformational changes lead to inser-
tion of a hydrophobic stretch of residues (the so-called mary isolates (viruses not extensively passaged in cul-
ture) exhibit a similar replication pattern in T cell linesfusion peptide) of HA into the host membrane. Subse-
quent to fusion peptide insertion, additional conforma- and macrophages and are also defined as T-tropic. In
contrast, most primary HIV-1 isolates grow poorly intional changes are thought to take place in HA that
eventually lead to membrane fusion (reviewed by Carr established T cell lines but will replicate efficiently
in primary lymphocytes, as well as in monocytes andand Kim, 1994).
The human immunodeficiency virus type 1 envelope macrophages, and are referred to as macrophage- or
M-tropic. Importantly, the macrophage-tropic strains(HIV-1Env) has a number of proposed structural features
that are very similar to HA and suggest a common mech- more closely resemble viruses present early and
throughout the course of HIV-1 infection. It appears thatanism of entry. However, most retroviruses, including
HIV-1, enter cells in a pH-independent manner, and thus the macrophage-tropic viruses are primarily responsible
for transmission of HIV-1. The viral determinant oflow pH cannot be the signal for the requisite conforma-
tional changes. It has been proposed that, for HIV-1, T- and M-tropism maps to the gp120 subunit of the
HIV-1 envelope protein. Alterations in the third variablereceptor recognition may serve as the trigger that initi-
ates these conformational changes. Therefore, analysis regionof gp120(the V3 loop)specifyM- versusT-tropism.
Definition of viruses with distinct tropisms in humanof the virus–receptor interaction is likely to be critical for
understandingentry of HIV-1. CD4has been identified as cells suggested that cell type–specific cofactors might
be required in addition to CD4 for HIV-1 entry. It wasa receptor for the human immunodeficiency virus types
1 and 2 (HIV-1 and HIV-2) as well as for simian immuno- unclear for quite some time whether these cofactors
were the same factor(s) that determined the speciesdeficiency virus. Although CD4 binds tightly to the HIV-1
envelope glycoprotein gp120, expression of CD4 is not specificity of HIV-1 infection. As discussed below, this
question has now been answered.sufficient to allow HIV-1 entry into nonhuman cells, and
a cofactor that functions in conjunction with CD4 has Chemokines and HIV-1 Entry
Two separate sets of observations demonstrate thatbeen postulated (Maddon et al., 1986). However, a re-
cent breakthrough has caused an upheaval in the field chemokines are potent modulators of HIV-1 infection.
First, CD81 T lymphocytes have been shown to releaseof HIV-1 entry that is likely also to have profound implica-
tions on studies of HIV-1 pathogenesis, development of protein factors that inhibit HIV-1 replication (Cocchi et
al., 1995). Purification and sequencing of these proteinsnovel therapeutics and small animal models, and analy-
sis of natural resistance to infection. This breakthrough reveal that they are the chemokines macrophage–
inflammatory protein-1a and -1b (MIP-1a and MIP-1b)is the identification of several members of the chemo-
kine receptor family as coreceptors required for HIV-1 and RANTES (for regulated on activation normal T cell
expressed and secreted). These proteins are membersinfection. With all the players sufficient for HIV-1 entry
now identified, studies on the mechanism of entry by of the CC family of chemokines (reviewed by Horuk,
1994; Murphy, 1994).this virus can now proceed.
HIV-1 Entry into Host Cells A second observation implicating chemokines as in-
hibitors of HIV-1 entry comes from studies by Koup andThe HIV-1 envelope (Env) glycoproteins gp120 (SU) and
gp41 (TM) mediate HIV-1 infection of target cells. Like coworkers of individuals who have been exposed to
HIV-1 multiple times but remain uninfected (Paxton et al.,many other viral glycoproteins, they direct binding to
the cell and are critical for the fusion of viral and host 1996). CD4-positive lymphocytes from these individuals
are relatively resistant to infection by HIV-1 in culture,membranes. HIV-1 requires a host protein, CD4, on tar-
get cells for efficient infection. CD4 binds tightly (KD 1–2 yet the cells have normal levels of surface CD4. This
resistance is restricted to the M-tropic strains of HIV-1nM) to the viral envelope surface glycoprotein, gp120.
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Figure 1. Model for HIV-1 Coreceptor Use
Macrophage-tropic (M) and T-tropic (T) HIV-1
both bind to CD4 (triangles) during entry into
host cells. Macrophage-tropic viruses also
require chemokine receptors (circle) as a co-
receptor, while T-tropic viruses use fusin
(square) as a coreceptor.
and is associated with the secretion of high levels of Other Coreceptors for HIV-1:
Chemokine ReceptorsRANTES, MIP-1a, and MIP-1b by the CD41 T lympho-
The discovery of fusin, coupled with the observed ef-cytes from these individuals. The nature of the chemo-
fects of the CC chemokines RANTES, MIP-1a, and MIP-kine effect onHIV-1 infection is clarified somewhat when
1b on infection by M-tropic HIV-1 viruses, strongly sug-the coreceptors for HIV-1 entry are identified (see
gests that other chemokine receptor family membersbelow).
might display coreceptor function for the M-tropic vi-Fusin: A Coreceptor for HIV-1 Entry
ruses. Six receptors for the CC family of chemokinesOver ten years elapsed after the identification of CD4
have been identified: CC-CKR1, CC-CKR2, CC-CKR3,as a HIV-1 receptor before a coreceptor for HIV-1 entry
CC-CKR4, CC-CKR5, and the Duffy blood group anti-was identified. This molecule has been quite elusive
gen. All these proteins are seven transmembrane–despite significant efforts aimed at identifying it. There
domain, G protein–coupled receptors (see reviews byhave been a number of false starts along the way. How-
Horuk, 1994; Murphy, 1994). In general, there is broadever, in a recently published series of elegant experi-
overlap in the ligands bound by the CC chemokine re-ments utilizing a sensitive fusion-assay system, Berger
ceptors, and many bind RANTES, MIP-1a, and MIP-1b.and colleagues have identified a protein they call fusin
Characterization of the receptor expression patterns isthat when coexpressed with CD4 in murine NIH 3T3 cells
incomplete.allows fusion with cells bearing HIV-1 envelope proteins
Using both HIV-1 infection assays and Env-mediated(Feng et al., 1996; Figure 1). Furthermore, expression of
cell–cell fusion experiments, several groups tested theCD4 and fusin in a number of different nonhuman cells
known receptors for the CC family of chemokines byrenders them susceptible to infection with HIV-1. Anti-
transient transfection into cells and assessed HIV-1 co-bodies directed against fusin blocks Env-mediated fu-
receptor function. Nearly simultaneously, five groupssion and infection in human cells normally permissive
reported that CC-CKR5 was the major coreceptor for
for HIV-1. From these results, it is clear that fusin is a
the macrophage-tropic strains of HIV-1 (Figure 1). CC-
bona fide coreceptor for HIV-1. The specific requirement
CKR5 allows both membrane fusion and infection by
for human fusin and human CD4 explains the species numerous strains of M-tropic viruses (Alkhatib et al.,
tropism displayed by HIV. 1996; Choe et al., 1996; Deng et al., 1996; Doranz et al.,
When analyzed with Env’s from various viral types, 1996; Dragic et al., 1996). RANTES, MIP-1a, and MIP-
fusin has been shown specifically to mediate T-tropic 1b, the chemokine ligands for this receptor that had
viral fusion and entry but not to function as a coreceptor previously been demonstrated to inhibit HIV-1 infection,
for the macrophage-tropic viral Env’s. Fusin mRNA is have been shown to block HIV-1 Env-mediated mem-
expressed in numerous cell types permissive for brane fusion directed by CC-CKR5 (Alkhatib et al., 1996;
T-tropic HIV-1 viruses, including peripheral bloodmono- Dragic et al., 1996). It appears that CC-CKR5 is the major
nuclear cells, Jurkat T cells, HeLa cells, and H9 cells. M-tropic HIV-1 cofactor. However, as discussed below,
Therefore, fusin also fulfills these criteria for the T cell– there is some flexibility in the choice of CC-CKR used
tropic cofactor, but the cofactor for macrophage-tropic as coreceptor for at least some M-tropic envelopes.
viruses remains to be identified. Although the macrophage-tropic viruses all appear to
The sequence of fusin reveals that it is a member of the utilize CC-CKR5, there are viral isolate–specific differ-
superfamily of G protein–coupled receptors containing ences in the use of other CC-CKRs for entry. For exam-
seven transmembrane segments and that it is most ple, the M-tropic HIV-1 strains ADA and YU2 appear to
closely related (37% identity) to the receptor for interleu- use CC-CKR3 inaddition toCC-CKR5 (Choe et al., 1996).
kin-8, a member of the CXC family of chemokines. Fusin A dual-tropic HIV-1, 89.6, is quite promiscuous in its
had been previously identified by several other labora- choice of coreceptor using the CC chemokine receptors
tories as an “orphan” chemokine receptor and given CC-CKR2b, CC-CKR3, and CC-CKR5, as well as fusin
the names LCR-1, HUMSTSR, and LESTR. The natural (Doranz et al., 1996, Choe et al., 1996). When genetically
ligand for fusin is presently unknown, but fusin does not distant strains of macrophage-tropic HIV-1 were exam-
ined for coreceptor use, all of these viruses were ablebind RANTES, MIP-1a, or MIP-1b.
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to utilize CC-CKR5. However, the viruses from clades blocking the viral access to the receptor using small
molecule inhibitors instead of chemokines.E and C did so at only approximately 10% the level of
the other viruses. The inability of envelope proteins from The role of the coreceptors in HIV-1 pathogenesis can
also be analyzed. Inappropriate signaling, mediated bythese clades to utilize efficiently any of the potential
coreceptors examined (CC-CKR1–5 or fusin) suggests direct interaction of HIV-1 envelope and the coreceptor,
could contribute to pathogenesis of the virus. In addi-that the clade E Env’s studied are either inherently less
efficient than the clade B envelopes or that they may tion, a number of chemokine receptor homologs have
been identified in DNA viruses, including human cyto-primarily utilize an alternative coreceptor. Taken to-
gether, the results showing diverse receptor utilization megalovirus and Herpes saimiri (a close relative of the
Kaposi sarcoma–associated herpes virus). It is interest-by the dual-tropic virus and the inefficient utilization of
the tested CKRs by the E and C clades suggest that the ing to speculate that interaction of HIV-1 with these
receptors could be involved in pathogenesis by theselist of chemokine receptors implicated as HIV-1 cofac-
tors is likely to grow. Furthermore, it also hints that the viruses that are associated with HIV-1 infection.
Finally, identification of factors (CD4 and fusin or CC-pattern of coreceptor utilization for various HIV-1 strains
will surely be quite complex (i.e., there is not likely to CKR5) sufficient for HIV-1 entry may allow development
of a small animal model for HIV-1 infection in which viralbe one coreceptor for all HIV-1 strains).
The region of HIV-1 envelope responsible for de- replication could be studied and therapeutic interven-
tions might be tested.termining coreceptor utilization was examined by So-
droski and coworkers using chimeric envelope proteins
Selected Reading(Choe et al., 1996). Substitution of the V3 loop from two
M-tropic strains into a T-tropic (HXB2) envelope gene
Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Murphy, P.M.,altered the coreceptor choice such that CC-CKR5 was
and Berger, E.A. (1996). Science, in press.
now used by these envelopes. Although a very limited
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overexpression, making it unavailable for the virus? Is
there genetic polymorphism in the CC-CKR receptors
that could account for the relative insensitivity of some
individuals to HIV-1 infection? If the polymorphic recep-
tors function less efficiently for both HIV-1 entry and
chemokine stimulation, one might expect observed viral
resistance and increased levels of chemokines. Also,
the chemokine receptors and/or chemokine levels might
determine the viral burden and thus the rate of disease
progression in infected individuals. The discovery of
chemokine receptors as cofactors may also lead to de-
velopment of new therapeutic strategies aimed at
